Concepedia

Publication | Open Access

Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy

DOIFull Paper Access

89

Citations

21

References

2018

Year

Michail Ignatiadis, Gert Van den Eynden, Roberto Salgado, Marco Fornili, Yacine Barèche, Christine Desmedt, Françoise Rothé, Marion Maetens, David Venet, Esther Holgado,
JNCI Journal of the National Cancer Institute

Abstract

Baseline TIL percentage provides independent prognostic information in patients treated with trastuzumab/pertuzumab-based neoadjuvant chemotherapy. However, further validation is required.

References

YearCitations

Page 1